Clinical application of synovial biopsy in noninflammatory and persistent inflammatory refractory rheumatoid arthritis
Annals of the Rheumatic Diseases · 2026-01 · 85 (1) · 91-102
DOI: 10.1016/j.ard.2025.07.023 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Annals of the Rheumatic Diseases, 2026-01. Verfasst von Alessandro Giollo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Unit, Department of Medicine, DIMED, University of Padova, Padova, Italy. Electronic address: alessandro.giollo@unipd.it. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Synovial Membrane, Synovitis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Ferrara.
Abstract (Originalsprache)
OBJECTIVES: We aimed to characterise the synovial pathology of refractory rheumatoid arthritis (RA) by comparing two hypothesised clinical phenotypes-persistent inflammatory refractory RA (PIRRA) and noninflammatory refractory RA (NIRRA)-against nonrefractory RA (NORRA). METHODS: We conducted a prospective, observational cohort study at two academic rheumatology centres. Adult patients with established RA and active disease (Clinical Disease Activity Index >10) underwent ultrasound-guided synovial tissue biopsies in accordance with European Alliance of Associations for Rheumatology-Outcome Measures in Rheumatology guidelines. Based on the Physician Global Assessment (>2/10) and C-reactive protein (>5 mg/L) thresholds, biological and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs)-inadequate responders patients were classified as PIRRA or NIRRA, whereas b/tsDMARD-naïve were designated NORRA. Histopathological assessments included the Krenn Synovitis Score (KSS) and immunohistochemistry pathotype evaluation (lympho-myeloid, diffuse-myeloid, pauci-immune/fibroid). RESULTS: Of the 93 biopsied patients, 43 were PIRRA, 21 NIRRA, and 29 NORRA. NIRRA had lower KSS (P = .012), lymphoid aggregates (P < .001) and predominantly pauci-immune/fibroid pathotype (n = 21/43, 47.6%), whereas PIRRA displayed more lympho- and diffuse-myeloid pathotypes, coupled with higher inflammatory markers and ultrasound-power Doppler scores. The relative risk of having pauci-immune fibroid synovitis for NIRRA was 1.6 (95% CI 1.2 to 2.9, P = .006), indicating a statistically significant increase in risk compared to PIRRA. Despite having similar overall disease activity scores, NIRRA patients reported significantly greater pain (P = .005) and higher opioid use (P = .015) than PIRRA, and worse health-related quality of life than PIRRA or NORRA, underscoring noninflammatory mechanisms. CONCLUSIONS: Our findings demonstrate distinct synovial and clinical phenotypes in refractory RA. Although PIRRA appears driven by active synovial inflammation and immune cell infiltration, NIRRA involves predominantly pauci-immune/fibroid histology with significant noninflammatory contributors to disease burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Rheumatology Unit, Department of Medicine, DIMED, University of Padova, Padova, Italy. Electronic address: alessandro.giollo@unipd.it.
- Rheumatology Unit, Department of Medicine, DIMED, University of Padova, Padova, Italy.
- Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna, Ferrara, Italy.
- Anatomic Pathology, Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
- Cardiovascular Pathology, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy.
Förderung
- Università degli Studi di Ferrara
Zitieren
APA
Giollo, A., Salvato, M., Frizzera, F., Khalid, K., Luozzo, L. D., Capita, M., Garaffoni, C., Lanza, G., Fedrigo, M., Angelini, A., Silvagni, E., & Doria, A. (2026). Clinical application of synovial biopsy in noninflammatory and persistent inflammatory refractory rheumatoid arthritis. Annals of the Rheumatic Diseases, 85(1), 91-102. https://doi.org/10.1016/j.ard.2025.07.023
Vancouver
Giollo A, Salvato M, Frizzera F, Khalid K, Luozzo LD, Capita M, et al. Clinical application of synovial biopsy in noninflammatory and persistent inflammatory refractory rheumatoid arthritis. Annals of the Rheumatic Diseases. 2026;85(1):91-102. doi:10.1016/j.ard.2025.07.023
BibTeX
@article{Giollo2026,
author = {Giollo, Alessandro and Salvato, Mariangela and Frizzera, Francesca and Khalid, Kiren and Luozzo, Lorenzo Di and Capita, Maria and Garaffoni, Carlo and Lanza, Giovanni and Fedrigo, Marny and Angelini, Annalisa and Silvagni, Ettore and Doria, Andrea},
title = {Clinical application of synovial biopsy in noninflammatory and persistent inflammatory refractory rheumatoid arthritis},
journal = {Annals of the Rheumatic Diseases},
year = {2026},
volume = {85},
number = {1},
pages = {91--102},
doi = {10.1016/j.ard.2025.07.023}
}
EUVIMED